Journal of Pharmacy Management - Jan 2022
AIM OF THE JoPM The aim of the JoPM is to play an influential part in shaping pharmacy practice. The JoPM provides a vehicle to enable healthcare professionals to stimulate ideas in colleagues and disseminate good practice that others can adapt or develop to suit their local circumstances. READERSHIP The JoPM is available on a controlled circulation basis to pharmacy teammembers and industry colleagues who work with them. To receive the JoPM, please go to www.pharman.co.uk , c lick on the ‘PM Journals’ tab and follow the process for registration. EDITORIAL BOARD Details of members of the Editorial Board are shown at the end of the journal. Their varied experience guides the development of the JoPM and ensures that it provides a useful resource for readers. PUBLISHING YOUR WORK Guidance for Authors is available under the 'Journals' tab at: www.pharman.co.uk . A ll submissions should be sent electronically to the Editor (
). The JoPM aims to follow the ‘Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals’ published by the International Committee of Medical Journal Editors (ICMJE) and known as ‘The Uniform Requirements’ and the Committee on Publication Ethics (COPE) ‘Code of Conduct’. PEER REVIEW/CLINICAL CONSULTANCY NETWORK The JoPM has a network of persons available to provide advice and undertake peer review of articles. Material that appears in the Best Practice and, as appropriate, the Clarion Call sections will have been subject to peer review. The peer review process is a form of quality control and advises on the suitability of an article for publication as well as constructive comment to assist authors, where appropriate, to develop their paper to a publishable standard. Authors are not informed of the name(s) of Peer Reviewers. Peer Reviewers are required to declare any conflicts of interest they have regarding a particular manuscript and to recuse themselves if these could complicate their review or inappropriately bias their opinion. Manuscripts are treated as confidential. It is a requirement that Peer Reviewers do not share or discuss it with colleagues, nor use knowledge of the work they are reviewing before its publication to further their own interests. Peer Reviewers provide advice to the Editor-in-Chief, who is ultimately responsible for the selection of all content. COMMUNICATION CHANNELS A learned journal should open its pages to scholarly debate and constructive comment and we hope that readers will share their views and questions in the following ways. LINKEDIN There is a JoPM LinkedIn Group. It is a closed group but everyone who requests the JoPM will be permitted to join. TWITTER Readers are encouraged to follow Pharmacy Management on @pharman to use our dedicated Twitter hashtag #(jopm). CORRESPONDENCE Please submit your correspondence to the Editor (
) an d declare any competing or conflicting interests when the correspondence is submitted. Correspondence may not be accepted if it is discourteous, inaccurate, potentially libellous, irrelevant, uninteresting or lacks cogency and may be edited for length, grammatical correctness, and journal style. Authors of articles discussed in correspondence will be given the opportunity to respond. The correspondence, together with a declaration of any interests and any subsequent comment from the author, may be published in the Journal and/or on the website. The correspondence, together with a declaration of any interests and any subsequent comment from the author, may be published in the Journal and/or on the website. READERS’ FEEDBACK The comments of readers on each edition of the journal are welcomed. Please use the hyperlink in the Readers' Feedback section to complete a short SurveyMonkey questionnaire. ADVERTISEMENTS/ADVERTORIALS Please contact the Advertising Editor (see end of journal) for more information. DISCLAIMER Published by: Pharman Limited, The Stable Yard, Vicarage Road, Stony Stratford, Buckinghamshire MK11 1BN Tel: 0333 800 2850 Homepage: see under the 'Journals' tab at: www.pharman.co.uk . Email:
All rights reserved. No part of this publication may be reproduced, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of Pharman Limited. The views represented in the Journal are those of authors and not necessarily those of the Editor or Pharmacy Management. Pharman Ltd is not responsible for the content or accuracy of commercially generated material (e.g. advertisements, sponsored articles) but has the expectation that the originators of such material will ensure that it meets the requirements of the ABPI ‘Code of Practice for the Pharmaceutical Industry’ or other relevant guidance. Prescribing Information may be amended subsequent to publication of the journal so it is important to always consult the latest available version. Although great care has been taken to ensure the accuracy and completeness of the information contained in this publication, Pharman Limited nor any of its authors, contributors, employees or advisors is able to accept any legal liability for any consequential loss or damage, however caused, arising as a result of any actions taken on the basis of the information contained in this publication. Pharman Ltd is not responsible for the content of material that is available through hyperlinks. Efforts have been made to ensure that there is no infringement of copyright but please provide notification if any infringement is suspected. Pharman Limited welcomes requests for reproduction of the publication, in particular for educational purposes. Please contact the publishing office for information. Copyright© Pharman Limited The above composite logo is a registered Trade Mark owned by the publishers Pharman Limited.
Made with FlippingBook